Erymax

   
Google
 
Web NewDrugInformation.com

Erymax


Drug - Erymax
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin
Multiple ingredients are in alphabetical order.

Strength - 2%
The potency of the active ingredient(s), Erythromycin. May repeat for multiple part products.

Applicant - MERZ PHARMS
The firm name holding legal responsibility for Erymax. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062508
The FDA assigned number to Erymax. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Erymax. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 11, 1985
The date Erymax was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Erymax. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Erymax is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merz Pharmaceuticals Llc
The full name of the firm holding legal responsibility for the new application of Erymax.

Erymax